Overview

Global Cell Viability Assays Market is estimated to value over USD 3.9 billion by 2026 end and register CAGR of over 7.1% by 2026 end.

Cell viability assays are technologies that are used for determining the cell strength in response to any tested drug. They are generally tested on a tissue, cell or an organ. Cell viability looks for the cells to identify any inorganic reaction which they aren’t supposed to follow and scale this reaction to mark its viability. This plays an important role in all forms of cell culture. Cell viability forms the basis of an assay to look out for drug effectiveness or cell viability with multiple combined particles and it also offers different characteristics of cell health to the user.

Cell viability assay is primarily performed in all in vitro and pharmaceutical studies due to increased applications of cell viability assays for drug screening. A large number of local manufacturers have expanded their cell viability assay kits product portfolio to determine effects in cell growth and cell death for the sake of clinical research and this has increased the demand for cell viability assays thus aiding the cell viability assays market size proliferation.

Key market players include Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, GE Healthcare, Danaher Corporation, Becton, Dickinson and Company, Promega Corporation, Biotium, Abcam PLC, Creative Bioarray, Biotek Instruments, Perkinelmer.

Global Cell Viability Assays Market Segmentation:

By Product

·     Consumables

o  Reagents

o  Assay Kits

§ Tetrazolium Reduction Assay Kits

·     Mtt Assay Kits

·     Other Tetrazolium Assay Kits

§ Resazurin Cell Viability Assay Kits

§ Calcein-Am Cell Viability Assay Kits

§ Other Assay Kits

o  Microplates

·     Instruments

o  Automated Cell Counters

o  Flow Cytometers

o  Spectrophometers

o  Cell Imaging & Analysis Systems

 By Cell Type

·     Human Cells

·     Animal Cells

·     Microbial Cells

By Application

·     Drug Discovery and Development

·     Basic Research

·     Stem Cell Research

·     Clinical and Diagnostic Applications

·     Other Applications

By Region

·     North America

·     Europe

·     Asia Pacific

·     Latin America

·     Middle East & Africa

Competitive Landscape:

·     Tier 1 players- established companies in the market with a major market share 

·     Tier 2 players 

·     Emerging players which are growing rapidly 

·     New Entrants

FutureWise Key Takeaways:

•   Growth prospects

•   SWOT analysis

•   Key trends

•   Key data-points affecting market growth

Objectives of the Study:

·     To provide with an exhaustive analysis on the global cell viability assays market by product, by cell type, by application and by region

·     To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

·     To evaluate and forecast micro-markets and the overall market

·     To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa

·     To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

·     Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Table of Contents

1 Introduction 

    1.1 Objectives of the Study 

    1.2 Market Definition 

    1.3 Market Scope 

           1.3.1 Markets Covered

           1.3.2 Years Considered for the Study

    1.4 Currency 

    1.5 Limitations 

    1.6 Stakeholders 

2 Research Methodology 

    2.1 Research Data 

           2.1.1 Secondary Sources

                    2.1.1.1 Key Data From Secondary Sources

           2.1.2 Primary Sources

                    2.1.2.1 Key Data From Primary Sources

    2.2 Market Size Estimation 

    2.3 Market Breakdown and Data Triangulation 

    2.4 Market Share Estimation 

    2.5 Assumptions for the Study 

3 Executive Summary 

4 Premium Insights 

    4.1 Cell Viability Assays Market Overview 

    4.2 Cell Viability Assays Market: Geographic Overview (2017) 

    4.3 Regional Mix: Cell Viability Assays Market (2018–2026) 

    4.4 Asia Pacific: Cell Viability Assays Market, By End User & Country (2017) 

    4.5 Cell Viability Assays Market: Developed vs Developing Markets 

5 Market Overview 

    5.1 Introduction 

    5.2 Market Dynamics 

           5.2.1 Drivers

                    5.2.1.1 Rising Incidence and Prevalence of Chronic and Infectious Diseases

                    5.2.1.2 Growing Availability of Funds for Research

                    5.2.1.3 Rising Demand for Cell-Based Assays in Research

                    5.2.1.4 Increasing Focus on the Development of Cell-Based Therapeutics

           5.2.2 Restraint

                    5.2.2.1 High Cost of Instruments

           5.2.3 Opportunities

                    5.2.3.1 Emerging Markets

                    5.2.3.2 Growing Focus on Stem Cell Research

6 Cell Viability Assays Market, By Product 

    6.1 Introduction 

    6.2 Consumables 

           6.2.1 Reagents

           6.2.2 Assay Kits

                    6.2.2.1 Tetrazolium Reduction Assay Kits

                               6.2.2.1.1 Mtt Assay Kits

                               6.2.2.1.2 Other Tetrazolium Assay Kits

                    6.2.2.2 Resazurin Cell Viability Assay Kits

                    6.2.2.3 Calcein-Am Cell Viability Assay Kits

                    6.2.2.4 Other Assay Kits

           6.2.3 Microplates

    6.3 Instruments 

           6.3.1 Automated Cell Counters

           6.3.2 Flow Cytometers

           6.3.3 Spectrophotometers

           6.3.4 Cell Imaging & Analysis Systems

7 Cell Viability Assays Market, By Cell Type 

    7.1 Introduction 

    7.2 Human Cells 

    7.3 Animal Cells 

    7.4 Microbial Cells 

8 Cell Viability Assays Market, By Application 

    8.1 Introduction 

    8.2 Drug Discovery and Development 

    8.3 Basic Research 

    8.4 Stem Cell Research 

    8.5 Clinical and Diagnostic Applications 

    8.6 Other Applications 

9 Cell Viability Assays Market, By End User 

    9.1 Introduction 

    9.2 Pharmaceutical & Biotechnology Companies 

    9.3 Academic & Research Institutes 

    9.4 Hospital & Diagnostic Laboratories 

    9.5 Other End Users 

10 Cell Viability Assays Market, By Region 

     10.1 Introduction 

     10.2 North America 

             10.2.1 US

             10.2.2 Canada

     10.3 Europe 

             10.3.1 Germany

             10.3.2 France

             10.3.3 UK

             10.3.4 Italy

             10.3.5 Spain

             10.3.6 Rest of Europe

     10.4 Asia Pacific 

             10.4.1 Japan

             10.4.2 China

             10.4.3 India

             10.4.4 Rest of Asia Pacific

     10.5 Latin America 

     10.6 Middle East & Africa 

11 Competitive Landscape 

     11.1 Overview 

     11.2 Market Share Analysis 

             11.2.1 Market Share Analysis: Cell Viability Assay Kits Market

     11.3 Competitive Situation and Trends 

             11.3.1 Product Launches

             11.3.2 Expansions

             11.3.3 Acquisitions

             11.3.4 Other Strategies

12 Company Profiles 

(Business Overview, Products Offered, Recent Developments, SWOT Analysis, FutureWise Perspective)*

     12.1 Thermo Fisher Scientific 

     12.2 Merck KGaA 

     12.3 Bio-Rad Laboratories 

     12.4 GE Healthcare 

     12.5 Danaher Corporation 

     12.6 Becton, Dickinson and Company 

     12.7 Promega Corporation 

     12.8 Biotium 

     12.9 Abcam PLC 

     12.10 Creative Bioarray 

     12.11 Biotek Instruments 

     12.12 Perkinelmer 

13. Research Finding and Conclusion 

14. Appendix 

15.1 Research Methodology 

15 .2 Research Data Source 

Tables

Figures